(Q35490630)

8 August 2017

Melatonin protects against myocardial hypertrophy induced by lipopolysaccharide (English)

1 reference

8 August 2017

0 references

Qi Lu

1

1 reference

8 August 2017

Xin Yi

2

1 reference

8 August 2017

Xiang Cheng

3

1 reference

8 August 2017

Xiaohui Sun

4

1 reference

8 August 2017

Xiangjun Yang

5

1 reference

8 August 2017

5 December 2014

1 reference

In Vitro Cellular & Developmental Biology - Animal

8 August 2017

1 reference

8 August 2017

51

1 reference

8 August 2017

353-360

1 reference

8 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11626-014-9844-0

8 August 2017

0 references

cites work

CaMKII in myocardial hypertrophy and heart failure

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Tumor necrosis factor-alpha in macrophages of heart, liver, kidney, and in the pituitary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Structural basis of end-stage failure in ischemic cardiomyopathy in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Does load-induced ventricular hypertrophy progress to systolic heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Oral melatonin attenuates lung inflammation and airway hyperreactivity induced by inhalation of aerosolized pancreatic fluid in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Inflammatory mediators and the failing heart: a translational approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Hypertrophy of the heart: a new therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Determinants of ventricular function in pressure-overload hypertrophy in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

What constitutes a physiological concentration of melatonin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

A review of the evidence supporting melatonin's role as an antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Roles of calcineurin and calcium/calmodulin-dependent protein kinase II in pressure overload-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Antifibrotic effect of melatonin--perspective protection in hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

The role of Ca2+/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Melatonin improved rat cardiac mitochondria and survival rate in septic heart injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11626-014-9844-0

Role of calcineurin in angiotensin II-induced cardiac myocyte hypertrophy of rats

21 January 2018

1 reference

12 December 2020

Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating

1 reference

12 December 2020

Protective actions of melatonin against heart damage during chronic Chagas disease

1 reference

12 December 2020

Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart

1 reference

12 December 2020

Ca2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy

1 reference

12 December 2020

Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men

1 reference

12 December 2020

Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II

1 reference

12 December 2020

Multiple protective effects of melatonin against maternal cholestasis-induced oxidative stress and apoptosis in the rat fetal liver-placenta-maternal liver trio

1 reference

12 December 2020

Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells

1 reference

12 December 2020

Increased expression of interleukin-1 beta and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload

1 reference

12 December 2020

A new generation of Ca2+ indicators with greatly improved fluorescence properties

1 reference

12 December 2020

Melatonin: an established antioxidant worthy of use in clinical trials.

1 reference

12 December 2020

Melatonin and cardioprotection in the acute myocardial infarction: a promising cardioprotective agent

1 reference

12 December 2020

Medical implications of melatonin: receptor-mediated and receptor-independent actions

1 reference

12 December 2020

Regulation of prostaglandin production in carrageenan-induced pleurisy by melatonin

1 reference

12 December 2020

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

12 December 2020

Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes

1 reference

12 December 2020

10.1007/S11626-014-9844-0

Identifiers

DOI

1 reference

8 August 2017

1 reference